GoodRx Holdings Inc [GDRX] stock is trading at $2.9, up 2.47%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GDRX shares have gain 7.81% over the last week, with a monthly amount glided 5.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GoodRx Holdings Inc [NASDAQ: GDRX] stock has seen the most recent analyst activity on December 09, 2025, when Barclays initiated its Underweight rating and assigned the stock a price target of $3. Previously, Raymond James downgraded its rating to Outperform on August 11, 2025. On December 04, 2024, Mizuho initiated with a Neutral rating and assigned a price target of $5 on the stock. Raymond James upgraded its rating to a Strong Buy but stick to its price target of $10 on August 09, 2024. RBC Capital Mkts upgraded its rating to an Outperform and raised its price target to $10 on May 23, 2024. Raymond James upgraded its rating to Outperform for this stock on May 16, 2024, but kept the price target unchanged to $10. In a note dated April 10, 2024, KeyBanc Capital Markets upgraded an Overweight rating on this stock but restated the target price of $9.
GoodRx Holdings Inc [GDRX] stock has fluctuated between $2.61 and $5.81 over the past year. Currently, Wall Street analysts expect the stock to reach $4.33 within the next 12 months. GoodRx Holdings Inc [NASDAQ: GDRX] shares were valued at $2.9 at the most recent close of the market. An investor can expect a potential return of 49.31% based on the average GDRX price forecast.
Analyzing the GDRX fundamentals
GoodRx Holdings Inc [NASDAQ:GDRX] reported sales of 800.65M for the trailing twelve months, which represents a growth of 0.40%. Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at 0.1%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.05 and Total Capital is 0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.91.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.84 points at the first support level, and at 2.78 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.94, and for the 2nd resistance point, it is at 2.98.
Ratios To Look Out For
For context, GoodRx Holdings Inc’s Current Ratio is 3.11. In addition, the Quick Ratio stands at 3.11 and the Cash Ratio stands at 1.5. Considering the valuation of this stock, the price to sales ratio is 1.23, the price to book ratio is 1.65 and price to earnings (TTM) ratio is 33.76.
Transactions by insiders
Recent insider trading involved Spectrum Equity VII, L.P., 10% Owner, that happened on Oct 15 ’25 when 23771.0 shares were sold. Affiliate, Spectrum VII Co-Investment Fun completed a deal on Oct 15 ’25 to buy 8569.0 shares. Meanwhile, Affiliate Spectrum VII Investment Manage bought 15202.0 shares on Oct 15 ’25.
